Aberrant overexpression of the TAL1 oncogenic transcription factor is found in ~50% of T cell acute lymphoblastic leukemias (T-ALL) and is associated with less favorable outcomes (39). This evidence concerns the gene TAL1 and acute lymphoblastic leukemia.